The Aricept® Evess study is a prospective, non-comparative, non-interventional study on use
of Aricept® Evess in the treatment of out-patients with AD and Vascular Dementia. The 24 week
length of the study aims to collect data from a large number of patients (n= 400) on the
safety and efficacy at the usual dosage of the product providing an overview of Aricept®
Evess profile.